Ligand | FPR | FPRL1 | FPRL2 | |||
---|---|---|---|---|---|---|
Kd | EC50 | Kd | EC50 | Kd | EC50 | |
Lipid-derived agonists | ||||||
LXA4 and ATL | 5 μM | 1.7 nM | ||||
Bacteria-derived peptides | ||||||
fMLF | 1 nM | >1 μM | >1 μM | |||
Hp(2—20) | 300 nM | |||||
Host-derived peptides | ||||||
uPAR fragment | 83 nM | |||||
Annexin 1 | 900 nM | |||||
MHC binding peptide | 1 nM | |||||
SAA | 45 nM | |||||
LL-37 | 5 μM | |||||
CKβ8-1 | >1 μM | 1 nM | 1 μM | |||
F2L | >1 μM | >1 μM | 10 nM | |||
HIV-1 envelope peptides | ||||||
T20/DP176 | ||||||
T21/DP107 | 500 nM | |||||
N36 | 10 μM | |||||
F peptide | 10 μM | |||||
V3 peptide | 1.5 μM | |||||
Synthetic peptides | ||||||
MMK-1 | 10 μM | 2 nM | ||||
WKYMVm | 1 nM | 75 pM | 3 nM | |||
Neuropeptides | ||||||
PrP106—126 | 10 μM | |||||
Aβ42 | 1.5 μM | |||||
Humanin | 3.5 nM |